In one paragraphArticle in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Maria OsmininaDepartment of Children's Diseases, Sechenov First Moscow State Medical University, 119435 Moscow, Russia.ORCID 0000-0003-3537-5390 Vera PodzolkovaDepartment of Children's Diseases, Sechenov First Moscow State Medical University, 119435 Moscow, Russia.ORCID 0000-0002-0701-5956 Maria LitvinovaDepartment of Medical Genetics and Postgenomic Technologies, Sechenov First Moscow State Medical University, 119435 Moscow, Russia.ORCID 0000-0002-1863-3768 Natalia GeppeDepartment of Children's Diseases, Sechenov First Moscow State Medical University, 119435 Moscow, Russia.ORCID 0000-0003-0547-3686 Svetlana ChebyshevaDepartment of Children's Diseases, Sechenov First Moscow State Medical University, 119435 Moscow, Russia.
Lusine KhachatryanDepartment of Children's Diseases, Sechenov First Moscow State Medical University, 119435 Moscow, Russia.ORCID 0000-0002-2125-569X Natalia GolovanovaDepartment of Children's Diseases, Sechenov First Moscow State Medical University, 119435 Moscow, Russia.ORCID 0000-0003-0813-1155 Yulia KostinaClinic of Children's Diseases, Sechenov's Center of Maternity and Childhood, 119435 Moscow, Russia.ORCID 0000-0002-6389-5177 Oksana Lazareva-BatyrevaClinic of Children's Diseases, Sechenov's Center of Maternity and Childhood, 119435 Moscow, Russia.
Angelina PolyanskayaDepartment of Children's Diseases, Sechenov First Moscow State Medical University, 119435 Moscow, Russia.ORCID 0000-0002-4125-0335 Olga ShpitonkovaDepartment of Children's Diseases, Sechenov First Moscow State Medical University, 119435 Moscow, Russia.ORCID 0000-0001-8132-0169 Tatiana SubbotinaDepartment of Medical Genetics and Postgenomic Technologies, Sechenov First Moscow State Medical University, 119435 Moscow, Russia.ORCID 0009-0006-5444-2797 Tigran AreianN.V. Sklifosovsky Institute of Clinical Medicine, Sechenov First Moscow State Medical University, 119048 Moscow, Russia.
Nadezhda PodchernyaevaDepartment of Children's Diseases, Sechenov First Moscow State Medical University, 119435 Moscow, Russia.ORCID 0000-0002-7498-1636 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Juvenile scleroderma (JS), comprising localized (JLSd) and systemic (JSSc) forms, is a rare autoimmune disorder. This study investigated associations of polymorphisms in extracellular matrix (
Indexed as
Genetic Predisposition to DiseaseImmunity, HumoralMatrix Metalloproteinase 9Nitric Oxide Synthase Type IIIPolymorphism, Single NucleotideScleroderma, LocalizedScleroderma, SystemicAdolescentCase-Control StudiesChildFemaleGenetic Association StudiesGenotypeHumansMaleMatrix Metalloproteinase 1Matrix Metalloproteinase 1Matrix Metalloproteinase 9MMP9 protein, humanNitric Oxide Synthase Type IIINOS3 protein, humanautoantibodiesbiomarkers of fibrosisgenetic associationgenetic factorsgenetic predispositionjuvenile localized sclerodermajuvenile sclerodermajuvenile systemic sclerosisMMP1MMP9NOS3rs1799983rs3918242single nucleotide polymorphism
Identifiers
PMID41596747
PMCPMC12841920
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390